FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 73177-127 | 73177-127-05 | Potassium Chloride | Potassium Chloride | 2 meq/1 mL | 2025-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-159 | 73177-159-02 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-159 | 73177-159-03 | Rocuronium Bromide | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-109 | 73177-109-26 | Ropivacaine | Ropivacaine | 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-02 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| STAQ Pharma Inc | 73177-116 | 73177-116-03 | Succinylcholine Chloride | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| STASKA PHARMACEUTICALS, INC. | 80098-030 | 80098-030-90 | ISOSULFAN BLUE 10MG/ML | ISOSULFAN BLUE | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-10 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-001 | 73217-001-15 | Tacrolimus 0.02% Ophth | Tacrolimus | .2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-15 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-002 | 73217-002-10 | Tacrolimus 0.03% Ophth | Tacrolimus | .3 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-003 | 73217-003-10 | Tacrolimus 0.1% Ophth | Tacrolimus | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-007 | 73217-007-10 | Tacrolimus 0.3% Ophth | Tacrolimus | 3 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-004 | 73217-004-10 | Tacrolimus 0.5% Ophth | Tacrolimus | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Stokes Healthcare | 73217-005 | 73217-005-10 | Tacrolimus 1% Ophth | Tacrolimus | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Tailstorm Health INC | 118651212 | 81483-0041 | 81483-0041-5 | Bevacizumab | 1.25 mg/.05 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0031 | 81483-0031-0 | Water | 1 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0036 | 81483-0036-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 5 ug/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0006 | 81483-0006-0 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0007 | 81483-0007-2 | Ketamine Hydrochloride | 100 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0007 | 81483-0007-0 | Ketamine Hydrochloride | 100 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0019 | 81483-0019-0 | Labetalol Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0000 | 81483-0000-0 | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0000 | 81483-0000-1 | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0037 | 81483-0037-0 | Lidocaine Hydrochloride; Epinephrine Bitartrate | 10 mg/1 mL; 10 ug/1 mL | 2025-2 | valid | 2026-10-17 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0061 | 81483-0061-0 | Lorazepam | 2 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| Tailstorm Health INC | 81483-0041 | 81483-0041-5 | Avastin | Bevacizumab | 1.25 mg/.05 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0036 | 81483-0036-0 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | 5 ug/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0007 | 81483-0007-0 | Ketamine 100 mg/mL 5mL | Ketamine Hydrochloride | 100 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0007 | 81483-0007-2 | Ketamine 100 mg/mL 5mL | Ketamine Hydrochloride | 100 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0006 | 81483-0006-0 | Ketamine 10mg/mL. 5mL | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0019 | 81483-0019-0 | LABETALOL | LABETALOL | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0000 | 81483-0000-0 | Lidocaine 10mg/mL | Lidocaine Hydrocholride | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0000 | 81483-0000-1 | Lidocaine 10mg/mL | Lidocaine Hydrocholride | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0037 | 81483-0037-0 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | 10 mg/1 mL; 10 ug/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0061 | 81483-0061-0 | Lorazepam 2mg/mL. 1mL | Lorazepam | 2 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| TAILSTORM HEALTH INC | 81483-0031 | 81483-0031-0 | Sterile Water | Sterile Water | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Turbare Manufacturing | 118984002 | 83556-0101 | 83556-0101-1 | Bevacizumab | 1.25 mg/.05 mL | 2025-2 | valid | 2026-10-17 | |
| Turbare Manufacturing | 118984002 | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| Turbare Manufacturing | 118984002 | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | 22.5 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| Turbare Manufacturing | 83556-0101 | 83556-0101-1 | Avastin 1.25mg/0.05mL | Repackaged Avastin 1.25mg/0.05mL | 1.25 mg/.05 mL | 2025-2 | valid | 2026-09-18 | |
| Turbare Manufacturing | 83556-0422 | 83556-0422-2 | Ceftazidime 22.5mg/mL | Ceftazidime 22.5mg/mL | 22.5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Turbare Manufacturing | 83556-0510 | 83556-0510-2 | Vancomycin 10mg/mL | Vancomycin 10mg/mL | 10 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| US Specialty Formulations LLC | 079181064 | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 5 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| US Specialty Formulations LLC | 69389-064 | 69389-064-22 | Sarracenia Purpurea | Sarracenia Purpurea | 5 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Wedgewood Connect | 079215020 | 79926-068 | 79926-068-05 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-10-17 | |
| Wedgewood Connect | 79926-068 | 79926-068-05 | Moxifloxacin | Moxifloxacin | 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Wells Pharma of Houston | 055774114 | 73702-123 | 73702-123-10 | Phenylephrine Hydrochloride | 40 ug/1 mL | 2025-2 | valid | 2026-10-17 | |
| Wells Pharma of Houston | 055774114 | 73702-122 | 73702-122-03 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2025-2 | valid | 2026-10-17 | |
| Wells Pharma of Houston | 055774114 | 73702-124 | 73702-124-10 | Phenylephrine Hydrochloride | 80 ug/250 mL | 2025-2 | valid | 2026-10-17 |